130 related articles for article (PubMed ID: 18295188)
21. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells.
Szebeni J; Patel SS; Hung K; Wahl LM; Weinstein JN
Antimicrob Agents Chemother; 1991 Jan; 35(1):198-200. PubMed ID: 2014977
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U).
Elwell LP; Ferone R; Freeman GA; Fyfe JA; Hill JA; Ray PH; Richards CA; Singer SC; Knick VB; Rideout JL
Antimicrob Agents Chemother; 1987 Feb; 31(2):274-80. PubMed ID: 3551832
[TBL] [Abstract][Full Text] [Related]
23. Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
Odriozola L; Cruchaga C; Andréola M; Dollé V; Nguyen CH; Tarrago-Litvak L; Pérez-Mediavilla A; Martínez-Irujo JJ
J Biol Chem; 2003 Oct; 278(43):42710-6. PubMed ID: 12917424
[TBL] [Abstract][Full Text] [Related]
24. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
Morris GW; Laclair DD; McKee EE
Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852
[TBL] [Abstract][Full Text] [Related]
25. Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity.
Tsuneyoshi K; Haraguchi M; Hongye Z; Gotanda T; Tachiwada T; Sumizawa T; Furukawa T; Baba M; Akiyama S; Nakagawa M
Cancer Lett; 2006 Dec; 244(2):239-46. PubMed ID: 16457948
[TBL] [Abstract][Full Text] [Related]
26. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Balzarini J; Herdewijn P; De Clercq E
J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
28. The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
Modica-Napolitano JS; Nalbandian R; Kidd ME; Nalbandian A; Nguyen CC
Cancer Lett; 2003 Jul; 198(1):59-68. PubMed ID: 12893431
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondria.
McCann KA; Williams DW; McKee EE
J Neurochem; 2012 Jul; 122(1):126-37. PubMed ID: 22530558
[TBL] [Abstract][Full Text] [Related]
30. Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.
Olivero OA; Vazquez IL; Cooch CC; Ming J; Keller E; Yu M; Borojerdi JP; Braun HM; McKee E; Poirier MC
Toxicol Sci; 2010 May; 115(1):109-17. PubMed ID: 20106944
[TBL] [Abstract][Full Text] [Related]
31. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
Pressacco J; Erlichman C
Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
33. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of 3'-azido-3'-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells.
Qian M; Bui T; Ho RJ; Unadkat JD
Biochem Pharmacol; 1994 Jul; 48(2):383-9. PubMed ID: 8053935
[TBL] [Abstract][Full Text] [Related]
35. Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine.
Agarwal RP; Wang W; Yo P; Han T; Fernandez M
Biochem Pharmacol; 1999 Nov; 58(10):1603-8. PubMed ID: 10535751
[TBL] [Abstract][Full Text] [Related]
36. Effects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat Model.
Snowdin JW; Hsiung CH; Kesterson DG; Kamath VG; McKee EE
Antimicrob Agents Chemother; 2015 Oct; 59(10):6328-36. PubMed ID: 26248377
[TBL] [Abstract][Full Text] [Related]
37. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
Chang S; Griesgraber GW; Southern PJ; Wagner CR
J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
40. Pro-oxidant properties of AZT and other thymidine analogues in macrophages: implication of the azido moiety in oxidative stress.
Amatore C; Arbault S; Jaouen G; Koh AC; Leong WK; Top S; Valleron MA; Woo CH
ChemMedChem; 2010 Feb; 5(2):296-301. PubMed ID: 20063338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
